Jean‐Pierre Cazenave

20.8k total citations
444 papers, 16.1k citations indexed

About

Jean‐Pierre Cazenave is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Jean‐Pierre Cazenave has authored 444 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Hematology, 102 papers in Cardiology and Cardiovascular Medicine and 67 papers in Molecular Biology. Recurrent topics in Jean‐Pierre Cazenave's work include Platelet Disorders and Treatments (123 papers), Antiplatelet Therapy and Cardiovascular Diseases (91 papers) and Blood Coagulation and Thrombosis Mechanisms (61 papers). Jean‐Pierre Cazenave is often cited by papers focused on Platelet Disorders and Treatments (123 papers), Antiplatelet Therapy and Cardiovascular Diseases (91 papers) and Blood Coagulation and Thrombosis Mechanisms (61 papers). Jean‐Pierre Cazenave collaborates with scholars based in France, Switzerland and Canada. Jean‐Pierre Cazenave's co-authors include Christian Gachet, François Lanza, Béatrice Hechler, Catherine Léon, Monique Freund, Philippe Ohlmann, Daniel Hanau, Anita Eckly, Alain Beretz and Henri de la Salle and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jean‐Pierre Cazenave

436 papers receiving 15.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Pierre Cazenave France 70 6.0k 4.0k 3.4k 2.8k 2.0k 444 16.1k
Bruce Furie United States 72 7.0k 1.2× 2.2k 0.5× 5.6k 1.6× 3.3k 1.2× 1.5k 0.8× 238 19.1k
Barbara C. Furie United States 58 5.9k 1.0× 1.9k 0.5× 4.1k 1.2× 2.1k 0.8× 1.3k 0.7× 156 14.8k
Lawrence F. Brass United States 69 6.7k 1.1× 2.2k 0.6× 3.8k 1.1× 2.0k 0.7× 1.0k 0.5× 188 13.3k
J. F. Mustard Canada 60 4.5k 0.8× 3.5k 0.9× 1.6k 0.5× 769 0.3× 1.9k 1.0× 300 11.5k
Shaun P. Jackson Australia 61 5.3k 0.9× 2.5k 0.6× 3.0k 0.9× 1.4k 0.5× 1.6k 0.8× 156 11.3k
Andrew S. Weyrich United States 70 4.8k 0.8× 2.3k 0.6× 4.1k 1.2× 4.1k 1.4× 1.5k 0.8× 169 15.2k
James G. White United States 63 5.6k 0.9× 1.8k 0.5× 3.8k 1.1× 2.6k 0.9× 1.5k 0.7× 447 16.4k
Eric Jaffe United States 38 3.5k 0.6× 1.8k 0.4× 5.5k 1.6× 2.5k 0.9× 1.5k 0.8× 89 15.6k
Denisa D. Wagner United States 90 6.8k 1.1× 2.7k 0.7× 7.4k 2.2× 13.5k 4.8× 2.2k 1.1× 202 28.0k
Meinrad Gawaz Germany 82 6.4k 1.1× 11.6k 2.9× 5.5k 1.6× 4.2k 1.5× 5.8k 2.9× 607 26.7k

Countries citing papers authored by Jean‐Pierre Cazenave

Since Specialization
Citations

This map shows the geographic impact of Jean‐Pierre Cazenave's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Pierre Cazenave with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Pierre Cazenave more than expected).

Fields of papers citing papers by Jean‐Pierre Cazenave

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Pierre Cazenave. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Pierre Cazenave. The network helps show where Jean‐Pierre Cazenave may publish in the future.

Co-authorship network of co-authors of Jean‐Pierre Cazenave

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Pierre Cazenave. A scholar is included among the top collaborators of Jean‐Pierre Cazenave based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Pierre Cazenave. Jean‐Pierre Cazenave is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Cazenave, Jean‐Pierre, et al.. (2009). Active Hemovigilance of Pediatric Patients Supported With Plasma Components Prepared With Photochemical Treatment. DIAL (Catholic University of Leuven). 94. 279–280. 1 indexed citations
3.
Maître, Blandine, Catherine Angénieux, Jean Salamero, et al.. (2008). Control of the Intracellular Pathway of CD1e. Traffic. 9(4). 431–445. 16 indexed citations
4.
Hechler, Béatrice, Monique Freund, Catherine Ravanat, et al.. (2008). Reduced Atherosclerotic Lesions in P2Y 1 /Apolipoprotein E Double-Knockout Mice. Circulation. 118(7). 754–763. 58 indexed citations
5.
Aleil, Boris, et al.. (2004). La glycoprotéine V soluble : un nouveau marqueur plasmatique de la thrombose artérielle. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
6.
Bubnoff, Dagmar von, et al.. (2002). Kinetics of Gene Induction After FcεRI Ligation of Atopic Monocytes Identified by Suppression Subtractive Hybridization. The Journal of Immunology. 169(11). 6170–6177. 18 indexed citations
7.
Deplanque, G., et al.. (2000). Caffeine does not cause override of the G2/M block induced by UVc or gamma radiation in normal human skin fibroblasts. British Journal of Cancer. 83(3). 346–353. 10 indexed citations
8.
Gachet, Christian, et al.. (1997). Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
9.
Folléa, Gilles, et al.. (1996). Don du sang et transfusion en Alsace. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
10.
Meyer, C, et al.. (1996). Xenograft rejection: molecular mechanisms and therapeutic prospects. PubMed. 38(4). 331–343. 11 indexed citations
11.
Gachet, Christian, Marco Cattaneo, Philippe Ohlmann, et al.. (1995). Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. British Journal of Haematology. 91(2). 434–444. 103 indexed citations
12.
Vérin, P, et al.. (1995). Aporte de la amplificacion genica al diagnostico biologico de la toxoplasmosis. Archivos de la Sociedad Española de Oftalmología. 69(1). 15–18.
13.
Gachet, Christian, Daniel Hanau, Danièle Spehner, et al.. (1992). αIIBβ3 Integrin Dissociation Induced by EDTA Results in Formation of Birbeck Granule-Like Structures in Human Blood Platelets. Journal of Investigative Dermatology. 99(5). S27–S29. 6 indexed citations
14.
Cazenave, Jean‐Pierre, et al.. (1992). Contribution of a New PCR assay to the prenatal diagnosis of congenital toxoplasmosis. Prenatal Diagnosis. 12(2). 119–127. 66 indexed citations
15.
Hanau, Daniel, et al.. (1990). Possible Mechanism of Action of CD1a Antigens. Journal of Investigative Dermatology. 95(5). 503–505. 7 indexed citations
17.
Cazenave, Jean‐Pierre. (1986). Blood-surface interactions : biological principles underlying haemocompatibility with artificial materials. Elsevier eBooks. 33 indexed citations
18.
Doffoël, M, et al.. (1984). [Importance of disorders of primary hemostasis in the occurrence of upper digestive hemorrhage in cirrhosis].. PubMed. 20(4). 177–82. 1 indexed citations
19.
Oberling, F, Jean‐Pierre Cazenave, & Rebecca Waitz. (1972). Ultrastructure du tissu adipeux de la moelle hématopoïétique normale du lapin.. Pathologie Biologie. 20(7). 1 indexed citations
20.
Oberling, F, et al.. (1971). A propos de certains effets toxiques de la L-asparaginase en thérapeutique humaine.. 47(22). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026